About
Generics
Areas of Focus
Categories
BiosimilarsGeneric DrugTaiwan
Team (26)
Akis Chondrogiannis
Head of B2B and Export Markets
Lotus Pharmaceuticals
team_member
Bjartur Shen
Vice President, Strategies and Finance
Lotus Pharmaceuticals
executive
Dr. Saral Thangam
CEO of Norwich Clinical Services (CRO INDIA)
Lotus Pharmaceuticals
executive
Edin Buljubasic
Vice President, Legal and Compliance
Lotus Pharmaceuticals
executive
Eeling Chan, CPA
Taiwan Chief Financial Officer
Lotus Pharmaceuticals
executive
Ella Tsai
Head of Procurement
Lotus Pharmaceuticals
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
354
By Phase
PHASE3: 2PHASE4: 1
By Status
UNKNOWN: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT01245166Lead Sponsor
A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
PHASE3Unknown
220 participants
Started: Nov 30, 2010 · Completed: Dec 31, 2011
NCT00346606Lead Sponsor
The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
PHASE4Unknown
60 participants
Started: Jan 31, 2006
NCT00334178Lead Sponsor
Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
PHASE3Completed
74 participants
Started: Nov 30, 2004 · Completed: Sep 30, 2006
Locations (1)
Headquarters
Taipei, Taiwan
Map
Loading map...